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(57) ABSTRACT 
The present invention generally relates to a modi?ed Rubisco 
large subunit éN-Methyltransferase (Rubisco LSMT, or 
RLSMT). The present invention also relates to a modi?ed 
RLSMT-carbonic anhydrase (RLSMT-CA). This modi?ed 
RLSMT-CA improves the ef?ciency of the reduction of CO2 
during photosynthesis, Which may increase plant groWth 
rates. The present invention also relates to nucleic acids 
encoding the modi?ed RLSMT-CA or modi?ed RLSMT. 
Also, the present invention relates to cells including the modi 
?ed RLSMT-CA or modi?ed RLSMT, plants containing the 
modi?ed RLSMT-CA or modi?ed RLSMT, and methods 
using compositions of the present invention. In addition, the 
present invention relates to antibodies conjugated to CA 
Which may bind to Rubisco, and antibodies Which bind a 
modi?ed RLSMT-CA. The invention also relates to modi?ed 
forms of the LS and SS of Rubisco Where the modi?ed forms 
are fusions With CA or biologically active fragments thereof. 
The present invention provides methods of altering Rubisco 
carboxylase activity and altering plant groWth. 
14 Claims, 6 Drawing Sheets 
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MODIFIED RUBISCO LARGE SUBUNIT 
N-METHYLTRANSFERASE USEFUL FOR 
TARGETING MOLECULES TO THE 
AC TIVE-SITE VICINITY OF 
RIBULOSE-1,5-BISPHOSPHATE 
This Work Was supported by the US. Department of 
Energy grant DE-FG02-02-92ER20075, and therefore the 
government may have certain rights to the invention. 
This application is a divisional of US. application Ser. No. 
10/555,795, ?led Nov. 22, 2006, noW abandoned, Which is a 
371 of PCT/US2004/014393, ?led May 7, 2004, Which 
claims the bene?t of US. Provisional Application No. 
60/468,966, ?led May 8, 2003. 
FIELD OF THE INVENTION 
The present invention generally relates to a modi?ed 
Rubisco large subunit éN-Methyltransferase (Rubisco LSMT, 
or RLSMT). The modi?ed RLSMT is useful for targeting 
molecules to Rubisco. The present invention also relates to a 
modi?ed RLSMT-carbonic anhydrase (RLSMT-CA). This 
modi?ed RLSMT-CA improves the ef?ciency of the reduc 
tion of CO2 during photosynthesis, Which may increase plant 
groWth rates. The present invention also relates to nucleic 
acids encoding the modi?ed RLSMT-CA or modi?ed CA. 
Also, the present invention relates to cells including the modi 
?ed RLSMT-CA or modi?ed CA, plants containing the modi 
?ed RLSMT-CA or modi?ed RLSMT, and methods using 
compositions of the present invention. In addition, the present 
invention relates to antibodies conjugated to CA Which may 
bind to the large or small subunits of Rubisco. The present 
invention provides methods of altering Rubisco carboxylase 
activity and altering plant groWth. 
BACKGROUND 
Ribulose-1,5 -bisphosphate carboxylase-oxygenase 
(Rubisco) catalyzes the reduction of atmospheric CO2 during 
photosynthesis. This process is not e?icient and methods to 
improve the e?iciency of CO2 reduction are needed. Methods 
Which improve the ef?ciency of CO2 reduction Will increase 
plant groWth rates, Which Will be useful to a variety of indus 
tries. 
A great deal is knoWn about the quaternary structure, cata 
lytic mechanism, active site residues, in vivo regulatory 
mechanisms, and gene expression for this abundant enzyme, 
(see, for example, AndreWs et al., “Rubisco: Structure, 
Mechanisms, and Prospects for Improvement,” in Hatch et al. 
(eds), The Biochemistry ofPlants, vol, 10, pp. 131-218. Aca 
demic Press, York (1987); Dean et al., “Structure, evolution, 
and regulation of rbcS genes in higher plants,” Annu. Rev. 
PlanZPhysiol. PlanZMol. Biol. 40: 415-439 (1989); and Mul 
let, “Chloroplast development and gene expression,” Annu. 
Rev. Plant. Physiol. Plant Mol. Biol. 39: 475-502 (1988)). 
Higher plant Rubisco is a hexadecameric protein composed 
of eight chloroplast-encoded large subunits (referred to 
herein as “LS”) and eight nuclear-encoded small subunits 
(referred to herein as “SS”). Synthesis of the LS is accompa 
nied by post-translational processing of the N-ter'minal 
domain (Houtz et al., “Post-translational modi?cations in the 
large subunit of ribulose bisphosphate carboxylase/oxyge 
nase,” Proc. Natl. Acad. Sci. USA 86:1855-1859 (1989); and 
Mulligan et al., “Reaction-intermediate analogue binding by 
ribulose bisphosphate carboxylase/oxygenase causes speci?c 
changes in proteolytic sensitivity: The amino-terminal resi 
due of the large subunit is acetylated proline,” Proc. Natl. 
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Acad. Sci. USA 85:1513-1517 (1988)). The N-terminal Met-1 
and Ser-2 are removed and Pro-3 acetylated. Additionally, the 
LS of Rubisco from tobacco, muskmelon, pea, and several 
other species is post-translationally modi?ed by trimethyla 
tion of the e-amine of Lys-14 (Houtz et al., “Posttranslational 
modi?cations in the amino-terminal region of the large sub 
unit of ribulose-1,5-bisphosphate carboxylase/oxygenase 
from several plant species,” Plant Physiol. 98:1170-1174 
(1992); Houtz et al., “Post-translational modi?cations in the 
large subunit of ribulose bisphosphate carboxylase/oxyge 
nase,” Proc. Natl. Acad. Sci. USA 86: 1855-1859 (1989)). The 
enzyme responsible for this latter modi?cation is a highly 
speci?c chloroplast-localized S-adenosylmethionine 
(AdoMet):protein (lys) éN-methyltransferase (protein 
methylase III, Rubisco LSMT, EC 2.1.1.43) (Houtz et al., 
“Post-translational modi?cations in the large subunit of ribu 
lose bisphosphate carboxylase/oxygenase,” Proc. Natl. Acad. 
Sci. USA 86:1855-1859 (1989)). 
Rubisco LSMT has been a?inity puri?ed-8000-fold from 
pea chloroplasts and identi?ed as a monomeric protein With a 
molecular mass of ~57 kDa (Wang et al., “A?inity Puri?ca 
tion of Ribulose-1,5-bisphosphate Carboxylase/Oxygenase 
Large Subunit éN-Methyltransferase,” Protein Expression 
and Puri?cation 6:528-536 (1995)). Recently, Rubisco 
LSMT cDNAs have been cloned and sequenced from pea and 
tobacco (Klein et al., “Cloning and developmental expression 
of pea ribulose-1,5-bisphosphate carboxylase/oxygenase 
large subunit N-methyltransferase,” Plant Molecular Biol. 
27:249-261 (1995);Ying et a 1., “Organization and character 
ization of the ribulose-1,5-bisphosphate carboxylase/oxyge 
nase large subunit EN-methyltransferase gene in tobacco,” 
Plant Molecular Biology 32:663-671 (1996)). The deduced 
amino acid sequences of tobacco Rubisco LSMT has 64.5% 
identity and 75.3% similarity With the sequence of pea 
Rubisco LSMT, and both proteins contain several copies of a 
conserved imperfect leucine-rich repeat motifs (Ying et al., 
“Organization and characterization of the ribulose-1,5-bis 
phosphate carboxylase/oxygenase large subunit éN-methyl 
transferase gene in tobacco,” Plant Molecular Biology 
32:663-671 (1996)). 
Kaplan et al., in US. Pat. No. 6,320,101, addressed the 
need for increased ef?ciency of Rubisco CO2 reduction by 
over-expressing a gene in a cell. HoWever, the ef?ciency of 
CO2 reduction in this method is not optimal and there is a need 
for additional methods of altering Rubisco carboxylase activ 
ity. There is a need for improved methods of targeting mol 
ecules to Rubisco. 
SUMMARY 
The present invention relates to a modi?ed Rubisco large 
subunit éN-Methyltransferase (RLSMT). The modi?ed 
RLSMT may include a Rubisco large subunit or biologically 
active fragment thereof linked to a second molecule or bio 
logically active fragment thereof. The modi?ed RLSMT may 
have the ability to bind a Rubisco. 
In a further embodiment, upon binding of the modi?ed 
RLSMT to Rubisco, the concentration of the second molecule 
is increased at the active site of Rubisco. Upon binding of the 
modi?ed RLSMT to Rubisco, the concentration of another 
molecule may be increased at the active site of Rubisco. The 
second molecule may be carbonic anhydrase. The second 
molecule may be a phosphatase. The second molecule may be 
a 3-phosphoglycerate kinase, glyceraldehydes-3 -phosphate 
dehydrogenase, Rubisco Activase, Phosphoribulokinase, 
polylysine, or oxygenase, for example. The another molecule 
US 8,138,309 B2 
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may be CO2. The second molecule may alter Rubisco activity. 
The another molecule may alter Rubisco activity. 
The present invention relates to the polypeptide sequences 
of modi?ed RLSMTs, the nucleic acid sequences encoding 
modi?ed RLSMTs, expression vectors including the nucleic 
acid sequence encoding a modi?ed RLSMT operably linked 
to an expression control sequence, host cells expressing one 
or more modi?ed RLSMTs of the present invention, and 
plants and photosynthetic organisms containing host cells 
expressing one or more modi?ed RLSMTs of the present 
invention. The groWth of the plant containing the host cell 
may be altered. 
Aspects of the present invention relate to methods of 
increasing the e?iciency of CO2 reduction in a cell. This 
increased ef?ciency of CO2 reduction Will result in increased 
plant productivity. 
An embodiment of the present invention is a modi?ed 
Rubisco large subunit éN-Methyltransferase-carbonic anhy 
drase (RLSMT-CA). The modi?ed RLSMT-CA of the 
present invention may be linked to a carbonic anhydrase 
(CA). The modi?ed RLSMT-CA may have the ability to bind 
a Rubisco. The carboxylase activity of Rubisco may be 
altered upon binding of Rubisco to the modi?ed RLSMT-CA. 
The present invention relates to the polypeptide sequences 
of modi?ed RLSMT-CAs, the nucleic acid sequences encod 
ing modi?ed RLSMT-CAs, expression vectors including the 
nucleic acid sequence encoding a modi?ed RLSMT-CA oper 
ably linked to an expression control sequence, host cells 
expressing one or more modi?ed RLSMT-CAs of the present 
invention, and plants and photosynthetic organisms contain 
ing host cells expressing one or more modi?ed RLSMT-CAs 
of the present invention. The groWth of the plant containing 
the host cell may be altered. 
The modi?ed RLSMT-CAs of the present invention 
include Rubisco large subunit EN-Methyltransferase(s), 
Which have been linked to CA by a chemical. The modi?ed 
RLSMT-CAs of the present invention also include fusion 
proteins. The fusion proteins are encoded by a nucleic acid. 
The nucleic acid may include a ?rst nucleic acid encoding a 
Rubisco large subunit éN-Methyltransferase or biologically 
active fragment thereof. The nucleic acid may further include 
a second nucleic acid encoding a carbonic anhydrase or bio 
logically active fragment thereof. The order of these 
sequences may be reversed. 
In a further embodiment, the modi?ed RLSMT-CA may 
include an antibody or biologically active fragment thereof. 
The antibody may be linked to a CA or a biologically active 
fragment thereof. 
The present invention further relates to an antibody Which 
binds to a Rubisco large subunit EN-Methyltransferase. The 
antibody may be linked to or bind another molecule. The 
other molecule may be carbonic anhydrase. The Rubisco 
carboxylase activity may be altered upon binding of Rubisco 
to the RLSMT linked or bound to the antibody linked to or 
bound to the carbonic anhydrase. 
The present invention further relates to a modi?ed Rubisco 
subunit linked to a carbonic anhydrase (RSCA). The Rubisco 
subunit may be a Rubisco large subunit (LS) or a Rubisco 
small subunit (SS). The modi?ed Rubisco subunit may 
assemble into Rubisco. 
In a further embodiment, upon assembly of the modi?ed 
LS or SS into Rubisco, the concentration of a ?rst molecule is 
increased at the active site of Rubisco. Upon assembly of the 
modi?ed LS and/or SS into Rubisco, the concentration of a 
second molecule may be increased at the active sites of 
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Rubisco. The ?rst molecule may be carbonic anhydrase. The 
second molecule may be CO2. The ?rst or second molecule 
may alter Rubisco activity. 
The present invention relates to the polypeptide sequences 
of modi?ed RSCA, the nucleic acid sequences encoding 
modi?ed RSCA, expression vectors including the nucleic 
acid sequences encoding modi?ed RSCA operably linked to 
an expression control sequence, host cells expressing one or 
more modi?ed RSCAs of the present invention, and plants 
and photosynthetic organisms containing host cells express 
ing one or more modi?ed RSCA of the present invention. The 
groWth of the plant containing the host cell may be altered. 
The present invention further relates to an antibody Which 
binds to the LS or SS of Rubisco. The antibody may be linked 
to or bind another molecule. The other molecule may be 
carbonic anhydrase. The Rubisco carboxylase activity may 
be altered upon binding of the antibody linked to or bound to 
the carbonic anhydrase. 
A method of altering Rubisco carboxylase activity is pro 
vided including providing a modi?ed RLSMT-CA, modi?ed 
RSCA, modi?ed LSMT, a nucleic acid encoding a modi?ed 
RLSMT-CA, modi?ed RSCA, modi?ed LSMT, or an anti 
body conjugated to CA. 
A method of altering plant groWth is provided including 
providing a modi?ed RLSMT-CA, modi?ed RSCA, modi?ed 
LSMT, a nucleic acid encoding a modi?ed RLSMT-CA, 
modi?ed RSCA, modi?ed LSMT, or an antibody conjugated 
to CA. 
A particular embodiment is related to a method of deliver 
ing a molecule to the Rubisco active site. A Rubisco large 
subunit or small subunit is provided. A RLSMT is provided, 
Which binds the Rubisco large or small subunit, Wherein the 
Rubisco large and small subunits are integral components of 
Rubisco. The molecule to be delivered is bound to the 
RLSMT. 
BRIEF DESCRIPTION OF DRAWINGS 
The objects and advantages of the invention Will be under 
stood by reading the folloWing detailed description in con 
junction With the draWings in Which: 
FIGS. 1A-C illustrate an estimation of the binding a?inity 
of Wild-type pea Rubisco LSMT for PVDF-immobiliZed des 
(methyl) spinach Rubisco. 
FIGS. 2A-C illustrate the fractionation of human carbonic 
anhydrase II (HCAII)-Rubisco LSMT conjugate, Rubisco, 
Rubisco LSMT, and HCAII by chromatography on 
Sepharose 6B. 
FIGS. 3A-B illustrate the effect of HCAII conjugated to 
Rubisco LSMT on carboxylase activity of spinach and pea 
Rubisco. 
FIG. 4 illustrates kinetic analyses of Rubisco, Rubisco 
complexed With hCA, Rubisco complexed With hCA in the 
presence of acetaZolamide (AZ). 
FIG. 5 illustrates the puri?cation of RLSMT-CA fusion 
protein. 
FIG. 6A is the nucleic acid sequence of the RLSMT-CA 
(SEQ ID No.: 1). FIG. 6B is the amino acid sequence of the 
RLSMT-CA fusion protein (SEQ ID No.: 2). 
DETAILED DESCRIPTION OF THE PREFERRED 
EMBODIMENTS 
Unless otherWise stated, the folloWing terms used in the 
speci?cation and claims have the meanings given beloW: 
By “RLSMT” is meant a Rubisco large subunit éN-Meth 
yltransferase. 
US 8,138,309 B2 
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By “RLSMT-CA” is meant a Rubisco large subunit éN 
Methyltransferase-carbonic anhydrase. 
By “RSCA” is meant a Rubisco subunit-carbonic anhy 
drase. 
By “modi?ed RLSMT-CA” is meant contains modi?ca 
tions or molecules not found in the Wild-type RLSMT or 
Wild-type CA. 
By “Biologically active fragment” of a carbonic anhydrase 
is meant a polypeptide fragment of a carbonic anhydrase 
Which has the ability to facilitate the equilibrium betWeen 
dissolved HCO3i and CO2. 
By “Biologically active fragment” of Rubisco large sub 
unit éN-Methyltransferase is meant a polypeptide fragment of 
a Rubisco large subunit éN-Methyltransferase Which has the 
ability to bind to Rubisco. 
By a “vector” is meant a replicon, such as a plasmid, phage 
or cosmid, to Which another DNA segment may be attached 
so as to bring about the replication of the attached segment. 
General Description of the Present Invention 
The present invention relates to the delivery of compounds 
and enZymes to the active-site vicinity of Rubisco. The pres 
ence and/or increased concentration of compounds and 
enZymes near the active-site vicinity of Rubisco may result in 
an increase in the carboxylase activity or speci?city factor of 
Rubisco, for example. Increased carboxylase activity and 
speci?city factor result in increased biomass production and 
thus translate into increased food and ?ber production. 
As described herein, localiZation of CA to Rubisco sub 
stantially increases the ef?ciency of CO2 ?xation by Rubisco 
at loW C02. The delivery of enZymes such as Rubisco Acti 
vase may increase the e?icacy of Rubisco Activase activity, 
an enZyme knoWn to be essential for Rubisco activity. Also, 
the delivery of phosphatases speci?c for degradation of car 
boxyarabinitol-l-phosphate Would also be useful since this 
compound is a knoWn natural inhibitor of Rubisco activity 
that occurs in many plants. Furthermore the rapid metabolism 
of 3-phosphoglyceric acid, the immediate product of the car 
boxylase reaction, or 2-phosphoglycolate the immediate 
product of the oxygenase reaction, by targeting enZymes 
capable of metabolizing these products may also facilitate 
higher carboxylase activity or increases in the speci?city 
factor of Rubisco. Other polypeptides such as polylysine and 
other amino acid polymers may also be bene?cial by deliv 
ering additional carbon dioxide to Rubisco sequestered as 
carbamates on the amino acid amine groups. 
The interaction betWeen pea Rubisco LSMT and des(m 
ethyl) forrns of Rubisco is exceptionally tight and speci?c 
(see FIG. 1). The interaction in general at least involves 
regions from the carboxy-terminal region of the LS of 
Rubisco and the amino-terminal region of pea Rubisco 
LSMT as measured by the susceptibility of Cys-ll9 and 
Cys-l88 in pea Rubisco LSMT and Cys459 in the LS of 
spinach Rubisco to cross-linking by 1,6 Bismaleimidohexane 
(BMH, a homobifunctional sulfhydryl-speci?c cross-linking 
reagent). The interaction betWeen pea Rubisco LSMT and 
des(methyl)spinach Rubisco appears to be stoichiometric 
With l-4 monomers of pea Rubisco LSMT binding to each 
Rubisco holoenZyme. HoWever, the binding has synergistic 
characteristics With decreasing binding a?inity With increas 
ing number of bound pea Rubisco LSMT monomers. Other 
regions of Rubisco LS and/or Rubisco SS may also be 
involved in Rubisco LSMT binding. 
Given the tight binding of Rubisco LSMT to Rubisco, the 
present invention utiliZes the Rubisco LSMT to deliver mol 
ecules to the active-site vicinity of Rubisco. A number of 
molecules may be delivered to Rubisco in this fashion. This 
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provides utility for increasing the local concentration of a 
molecule at the active-site vicinity of Rubisco. 
Modi?ed Rubisco Large Subunit éN-methyltransferase 
A particular embodiment of the present invention relates to 
a modi?ed Rubisco large subunit éN-methyltransferase 
(RLSMT). The modi?ed RLSMT contains a Rubisco large 
subunit éN-methyltransferase or biologically active fragment 
thereof linked to a second molecule or biologically active 
fragment thereof. The modi?ed RLSMT has the ability to 
bind to Rubisco. The modi?ed RLSMT may result in an 
increase in the concentration of the second molecule near 
Rubisco. The second molecule may be carbonic anhydrase, a 
phosphatase, a 3-phosphoglycerate kinase, glyceraldehydes 
3-phosphate dehydrogenase, Rubisco Activase, Phosphor 
ibulokinase, polylysine, or oxygenase, for example. The 
increased concentration of the second molecule may increase 
the concentration of another molecule, such as CO2 for 
example, near Rubisco. For example, the another molecule 
may be an enZymatic product of the second molecule. For 
example, the another molecule may be a molecule that binds 
the second molecule. 
In a particular embodiment, the Rubisco large subunit éN 
methyltransferase is linked to the second molecule by a 
chemical. Representative chemicals useful for linking these 
molecules are Well-knoWn to one of skill in the art. In this 
example the linkage is through free amine groups using glu 
taraldehyde. The use of any reactive molecule capable of 
cross-linking tWo proteins is also contemplated in this 
embodiment. Non-limiting examples of such cross-linking 
reagents are APGi(p-AZidophenyl gloxal monohydrate)i 
speci?c for arginine residues, BMHi(Bismaleimidohex 
ane)ispeci?c for sulfhydryl groups, DSP (Lomant’s 
Reagent)i(Dithiobis[succinimidylpropionate])ispeci?c 
for amines, EGSi(Ethylene glycolbis-[succinimidylsucci 
nate])ispeci?c for amines, EDCi(l-Ethyl-3-[3-dimethy 
laminopropyl]-carboiimide Hydrochloride)ispeci?c for 
amines and carboxyls, MBSi(m-MaleimidobenZoyl-N-hy 
droxysuccinimide ester)ispeci?c for sulfhydryls and 
amines, HPGi(p-Hydroxyphenylglyoxal)ispeci?c for 
argine residues, SPDPi(N-Succinimidyl-3-[2-py 
ridyldithio]propioinate)ireactive With amines and sulhydr 
yls, Sulfo-SAPBi(Sulfosuccinimidyl 4-[p-aZidophenyl]bu 
tyrate)iamines and photoreactive, and BSOCOESi(Bis [2 
(succinimidooxycarbonyloxy)ethyl]sulfone)ireactive With 
amines. 
In a particular embodiment, the modi?ed RLSMT is a 
fusion protein. The fusion protein may be encoded by a 
nucleic acid sequence, Wherein the nucleic acid sequence 
comprises a ?rst nucleic acid sequence encoding a Rubisco 
large subunit éN-methyltransferase or biologically active 
fragment thereof, and Wherein the nucleic acid sequence fur 
ther comprises a second nucleic acid sequence encoding a 
polypeptide. Methods of molecular biology useful in these 
methods are Well-knoWn to one of skill in the art. In a par 
ticular embodiment, the second nucleic acid encodes car 
bonic anhydrase. In a particular embodiment, the second 
nucleic acid encodes a phosphatase. The second nucleic acid 
may encode a 3-phosphoglycerate kinase, glyceraldehydes 
3-phosphate dehydrogenase, Rubisco Activase, Phosphor 
ibulokinase, polylysine, or oxygenase, for example. The 
order of these sequences may be reversed. 
A particular embodiment of the present invention relates to 
a modi?ed Rubisco large subunit. The modi?ed RLS contains 
a Rubisco large subunit or biologically active fragment 
thereof linked to a second molecule or biologically active 
fragment thereof. 
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In a particular embodiment, the Rubisco large subunit is 
linked to the second molecule by a chemical. Representative 
chemicals useful for linking these molecules are Well-knoWn 
to one of skill in the art. 
In a particular embodiment, the modi?ed Rubisco large 
subunit is a fusion protein. The fusion protein may be encoded 
by a nucleic acid sequence, Wherein the nucleic acid sequence 
comprises a ?rst nucleic acid sequence encoding a Rubisco 
large subunit or biologically active fragment thereof, and 
Wherein the nucleic acid sequence further comprises a second 
nucleic acid sequence encoding a polypeptide. Methods of 
molecular biology useful in these methods are Well-knoWn to 
one of skill in the art. In a particular embodiment, the second 
nucleic acid encodes carbonic anhydrase. The order of these 
sequences may be reversed. 
A particular embodiment of the present invention relates to 
a modi?ed Rubisco small subunit. The modi?ed RSS con 
tains a Rubisco small subunit or biologically active fragment 
thereof linked to a ?rst molecule or biologically active frag 
ment thereof. 
In a particular embodiment, the Rubisco small subunit is 
linked to the second molecule by a chemical. Representative 
chemicals useful for linking these molecules are Well-knoWn 
to one of skill in the art. 
In a particular embodiment, the modi?ed Rubisco small 
subunit is a fusion protein. The fusion protein may be encoded 
by a nucleic acid sequence, Wherein the nucleic acid sequence 
comprises a ?rst nucleic acid sequence encoding a Rubisco 
small subunit or biologically active fragment thereof, and 
Wherein the nucleic acid sequence further comprises a second 
nucleic acid sequence encoding a polypeptide. Methods of 
molecular biology useful in these methods are Well-known to 
one of skill in the art. In a particular embodiment, the second 
nucleic acid sequence encodes carbonic anhydrase. The order 
of these sequences may be reversed. 
A particular embodiment of the present invention relates to 
a modi?ed carbonic anhydrase. The modi?ed carbonic anhy 
drase contains a carbonic anhydrase or biologically active 
fragment thereof linked to a ?rst molecule or biologically 
active fragment thereof. 
In a particular embodiment, the carbonic anhydrase is 
linked to the second molecule by a chemical. Representative 
chemicals useful for linking these molecules are Well-knoWn 
to one of skill in the art. 
In a particular embodiment, the modi?ed carbonic anhy 
drase is a fusion protein. The fusion protein may be encoded 
by a nucleic acid sequence, Wherein the nucleic acid sequence 
comprises a ?rst nucleic acid sequence encoding a carbonic 
anhydrase or biologically active fragment thereof, and 
Wherein the nucleic acid sequence further comprises a second 
nucleic acid sequence encoding a polypeptide. Methods of 
molecular biology useful in these methods are Well-knoWn to 
one of skill in the art. The order of these sequences may be 
reversed. Preferably, the second molecule is RLSMT, 
Rubisco LS, Rubisco SS, or a protein that binds either 
Rubisco LS or Rubisco SS. The second molecule may be 
Rubisco LSMT. Most preferably, the carboxylase activity of 
Rubisco is altered upon binding of the modi?ed carbonic 
anhydrase to Rubisco LS or Rubisco SS. 
In accordance With the present invention there may be 
employed conventional molecular biology, microbiology, 
immunology, and recombinant DNA techniques Within the 
skill of the art. Such techniques are explained fully in the 
literature. See, e.g., Sambrook et al, “Molecular Cloning: A 
Laboratory Manual” (3rd edition, 2001); “Current Protocols 
in Molecular Biology” Volumes I-IV [Ausubel, R. M., ed. 
(2002 and updated bimonthly)]; “Cell Biology: A Laboratory 
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Handbook” Volumes I-III [.I. E. Celis, ed. (1994)]; “Current 
Protocols in Immunology” Volumes I-IV [Coligan, J . E., ed. 
(2002 and updated bimonthly)]; “Oligonucleotide Synthesis” 
(M. J . Gait ed. 1984); “Nucleic Acid Hybridization” [B. D. 
Hames & S. J . Higgins eds. (1985)]; “Transcription And 
Translation” [B. D. Hames & S. J. Higgins, eds. (1984)]; 
“Culture of Animal Cells, 4”’ edition” [R. I. Freshney, ed. 
(2000)]; “Immobilized Cells And Enzymes” [IRL Press, 
(1986)]; B. Perbal, “A Practical Guide To Molecular Clon 
ing” (1988); Using Antibodies: A Laboratory Manual: Por 
table Protocol No. I, HarloW, Ed and Lane, David (Cold 
Spring Harbor Press, 1998); UsingAntibodies: A Laboratory 
Manual, HarloW, Ed and Lane, David (Cold Spring Harbor 
Press, 1999). 
Rubisco large subunit éN-methyltransferases useful in the 
present invention may be derived from any plant or photo 
synthetic organism. 
Upon binding of the modi?ed RLSMT to Rubisco, the 
concentration of the ?rst molecule may be increased at the 
active site of Rubisco. The ?rst molecule may be carbonic 
anhydrase or biologically active fragments thereof. The ?rst 
molecule may alter Rubisco activity. 
Upon binding of the modi?ed RLSMT to Rubisco, the 
concentration of a second molecule may be increased at the 
active site of Rubisco. The second molecule may be the 
product of a reaction catalyzed by the ?rst molecule. The 
second molecule may be C02. The second molecule may alter 
Rubisco activity. 
In a particular embodiment, the modi?ed Rubisco large 
subunit éN-methyltransferase is in a complex With carbonic 
anhydrase. The modi?ed Rubisco large subunit éN-methyl 
transferase may be linked to carbonic anhydrase or a biologi 
cally active fragment thereof. The modi?ed RLSMT-CA has 
the ability to bind Rubisco. Rubisco activity is altered When 
bound to the RLSMT-CA complex. 
In a particular embodiment, the Rubisco large subunit éN 
methyltransferase is linked to the carbonic anhydrase by a 
chemical. Representative chemicals useful for linking these 
molecules are Well-knoWn to one of skill in the art. 
In a particular embodiment, the modi?ed RLSMT-CA is a 
fusion protein. The fusion protein is encoded by a nucleic acid 
sequence, Wherein the nucleic acid sequence includes a ?rst 
nucleic acid sequence encoding a Rubisco large subunit éN 
methyltransferase or biologically active fragment thereof, 
and Wherein the nucleic acid sequence further includes a 
second nucleic acid sequence encoding a carbonic anhydrase 
or biologically active fragment thereof. The order of these 
sequences may be reversed. 
In a particular embodiment, the Rubisco complex With 
carbonic anhydrase includes an antibody. The antibody may 
be linked to a carbonic anhydrase. Preferably, the antibody 
may bind to Rubisco LS or Rubisco SS. 
In a particular embodiment, the Rubisco large subunit éN 
methyltransferase-CA complex is Within a cell. The cell may 
be prokaryotic or eukaryotic. The cell may be a plant cell or 
plant tissue. 
In a particular embodiment, the Rubisco large subunit éN 
methyltransferase-CA complex is in a photosynthetic organ 
ism. 
Rubisco Large Subunit éN-methyltransferase Carbonic 
Anhydrase 
An aspect of the present invention addresses the need to 
increase the rate of CO2 ?xation by Rubisco, Which is an 
inef?cient process in Wild-type plants. An increased rate of 
CO2 ?xation by Rubisco Will increase plant productivity, 
Which is useful in terms of food, ?ber, and biomass and is 
applicable to various aspects of agriculture. 
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At atmospheric levels of CO2, the carboxylase activity of 
Rubisco is limited. Additional limitations occur as a conse 
quence of competitive inhibition by 02. However, many 
plants possess mechanisms to alleviate this constraint, and 
increase the rate of CO2 ?xation by compartmentaliZation of 
Rubisco in conjunction With accumulation of inorganic car 
bon or CO2. An important part of this mechanism is carbonic 
anhydrase that facilitates equilibrium betWeen dissolved 
HCO3i and CO2. Given the tight and speci?c binding of 
Rubisco LSMT to des(methyl) forms of Rubisco, and the 
absence of any negative consequences from this binding on 
the catalytic activity of Rubisco, studies Were undertaken to 
target carbonic anhydrase (CA) to Rubisco utiliZing Rubisco 
LSMT. The results from these experiments demonstrate that 
localiZation of CA to Rubisco substantially increases the 
ef?ciency of CO2 ?xation by Rubisco at loW CO2. 
A particular embodiment of the present invention relates to 
a modi?ed Rubisco large subunit éN-methyltransferase-car 
bonic anhydrase (RLSMT-CA) complex, Wherein the 
Rubisco large subunit éN-methyltransferase is linked to car 
bonic anhydrase. This RLSMT-CA complex has the ability to 
bind to Rubisco, and Rubisco carboxylase activity is altered 
When bound to the RLSMT-CA complex. 
The reduction in the apparent af?nity for CO2 by the direct 
placement of CA to the active-site vicinity of Rubisco cir 
cumvents the kinetic constraints and enables Rubisco to 
maintain nearly saturated rates of carboxylase activity at air 
levels of CO2. 
Methods of the Present Invention 
A method of altering Rubisco carboxylase activity is pro 
vided including modifying CA by providing a modi?ed 
RLSMT-CA, a nucleic acid sequence encoding a RLSMT 
CA, or an antibody conjugated to CA. 
A method of altering plant groWth is provided including 
modifying the RLSMT-CA by providing a modi?ed RLSMT 
CA, a nucleic acid sequence encoding a RLSMT-CA, or an 
antibody conjugated to CA. 
A particular embodiment is related to a method of deliver 
ing a molecule to the vicinity of the Rubisco active site. A 
Rubisco large or small subunit is provided. A RLSMT is 
provided, Whichbinds the Rubisco large or small subunit. The 
molecule to be delivered is bound to the RLSMT. 
Antibody 
Also, antibodies including both polyclonal and mono 
clonal antibodies, and drugs that modulate the production or 
activity of the modi?ed RLSMT-CAs, modi?ed RLSMTs, 
Rubisco LSs, Rubisco SSs, and/or their biologically active 
fragments or subunits may be useful in the production or 
modi?cation of modi?ed RLSMT-CAs, modi?ed RLSMTs, 
Rubisco LSs, or Rubisco SSs. Antibodies may be conjugated 
to another molecule, such as a carbonic anhydrase. For 
example, RLSMT-CAs, modi?ed RLSMTs, Rubisco LSs, 
Rubisco SSs, or fragments or subunits thereof may be used to 
produce both polyclonal and monoclonal antibodies, to the 
RLSMT-CAs, modi?ed RLSMTs, Rubisco LSs, Rubisco 
SSs, or fragments or subunits thereof, in a variety of cellular 
media, by knoWn techniques such as the hybridoma technique 
utiliZing, for example, fused mouse spleen lymphocytes and 
myeloma cells. LikeWise, small molecules that mimic or 
antagoniZe the activity(ies) of the RLSMT-CAs, modi?ed 
RLSMTs, Rubisco LSs, or Rubisco SSs, of the invention may 
be discovered or synthesiZed, and may be used in diagnostic 
and/ or therapeutic protocols. 
The present invention also extends to the development of 
antibodies against the modi?ed RLSMT-CAs, modi?ed 
RLSMTs, Rubisco LSs, Rubisco SSs, including naturally 
raised and recombinantly prepared antibodies. For example, 
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the antibodies could be used to modulate Rubisco activity, or 
in the production or modulation of a modi?ed RLSMT-CA or 
modi?ed RLSMT. 
The general methodology for making monoclonal antibod 
ies by hybridomas is Well knoWn. Methods for producing 
monoclonal anti-modi?ed RLSMT-CA, modi?ed RLSMT, 
Rubisco LS, Rubisco SS, or Rubisco antibodies are also Well 
knoWn in the art. See Niman et al., Proc. Natl. Acad. Sci. USA, 
80:4949-4953 (1983). Typically, the modi?ed RLSMT-CA, 
modi?ed RLSMT, Rubisco LS, Rubisco SS, Rubisco or a 
peptide analog is used either alone or conjugated to an immu 
nogenic carrier, as the immunogen in the before described 
procedure for producing anti-modi?ed RLSMT-CA, modi 
?ed RLSMT, Rubisco LS, Rubisco SS, or Rubisco mono 
clonal antibodies. The culture is maintained under conditions 
and for a time period suf?cient for the hybridoma to secrete 
the antibodies into the medium. The hybridomas are screened 
for the ability to produce an antibody that immunoreacts With 
the modi?ed RLSMT-CA, modi?ed RLSMT, Rubisco LS, 
Rubisco SS, Rubisco or peptide analog. The antibody-con 
taining medium is then collected. The antibody can then be 
further isolated by Well-knoWn techniques. Immortal, anti 
body-producing cell lines can also be created by techniques 
other than fusion, such as direct transformation of B lympho 
cytes With oncogenic DNA, or transfection With Ep stein-Barr 
virus. See, e.g., Using Antibodies: A Laboratory Manual, 
HarloW, Ed and Lane, David (Cold Spring Harbor Press, 
1 999). 
Media useful for the preparation of these compositions are 
both Well-knoWn in the art and commercially available and 
include synthetic culture media, inbred mice and the like. An 
exemplary synthetic medium is Dulbecco’s minimal essential 
medium (DMEM; Dulbecco et al., Virol. 8:396 (1959)) 
supplemented With 4.5 gm/l glucose, 20 mm glutamine, and 
20% fetal calf serum. A preferred inbred mouse strain is the 
Balb/c. 
Methods for producing polyclonal anti-polypeptide anti 
bodies are Well-knoWn in the art. See US. Pat. No. 4,493,795 
to Nestor et al. A monoclonal antibody, and immunologically 
active fragments thereof, can be prepared using the hybri 
doma technology described in e.g., Using Antibodies: A 
Laboratory Manual, HarloW, Ed and Lane, David (Cold 
Spring Harbor Press, 1999), Which is incorporated herein by 
reference. Brie?y, to form the hybridoma from Which the 
monoclonal antibody composition is produced, a myeloma or 
other self-perpetuating cell line is fused With lymphocytes 
obtained from the spleen of a mammal hyperimmuniZed With 
a modi?ed RLSMT-CA, modi?ed RLSMT, Rubisco LS, 
Rubisco SS, or Rubisco. Splenocytes are typically fused With 
myeloma cells using polyethylene glycol (PEG) 6000 MW. 
Fused hybrids are selected by their sensitivity to HAT (hypox 
anthine, aminopterin, thymidine) supplemented media. 
Hybridomas producing a monoclonal antibody useful in prac 
ticing this invention are identi?ed by their ability to immu 
noreact With the present modi?ed RLSMT-CA, modi?ed 
RLSMT, Rubisco LS, Rubisco SS, or Rubisco and their abil 
ity to alter speci?ed modi?ed RLSMT-CA, modi?ed 
RLSMT, Rubisco LS, Rubisco SS, or Rubisco activity in 
target cells. 
Panels of monoclonal antibodies produced against modi 
?ed RLSMT-CA, modi?ed RLSMT, Rubisco LS, Rubisco 
SS, or Rubisco peptides can be screened for various proper 
ties, i.e., isotype, epitope, af?nity, and the like. High a?inity 
antibodies are also useful When immunoaf?nity puri?cation 
of native or recombinant modi?ed RLSMT-CA, modi?ed 
RLSMT, Rubisco LS, Rubisco SS, or Rubisco is possible. 
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Cells, Tissues, and Substrates 
The cells of the present invention may express at least one 
modi?ed Rubisco Large Subunit éN-methyltransferase. The 
cells may further comprise a conjugate of a carbonic anhy 
drase and Rubisco Large Subunit éN-methyltransferase. Use 
ful cells include eukaryotic and prokaryotic cells, including, 
but not limited to, bacterial cells, yeast cells, fungal cells, 
insect cells, nematode cells, plant cells, and animal cells. 
Suitable animal cells include, but are not limited to, HEK-293 
cells, U20S cells, HeLa cells, COS cells, and various primary 
mammalian cells. 
In a preferred embodiment of the present invention, the 
photosynthetic organism is a C3 plant. Non-limiting 
examples of C3 plants include spinach, Wheat, rice, and bar 
ley. 
The cells of the present invention may express one modi 
?ed Rubisco large subunit éN-methyltransferase that results 
in enhanced carbon ?xation upon expression in a plant. 
A substrate may have deposited thereon a plurality of cells 
of the present invention. The substrate may be any suitable 
biologically substrate, including but not limited to, glass, 
plastic, ceramic, semiconductor, silica, ?ber optic, diamond, 
biocompatible monomer, or biocompatible polymer materi 
als. 
Nucleic Acids Encoding Modi?ed Rubisco 
The present invention further includes nucleic acid mol 
ecules that encode modi?ed Rubisco large subunit éN-meth 
yltransferase. It should be appreciated that also Within the 
scope of the present invention are DNA sequences encoding 
modi?ed Rubisco large subunit éN-methyltransferase. 
The modi?ed Rubisco large subunit EN-methyltransferases 
may be generated by molecular biological techniques stan 
dard in the genetic engineering art, including but not limited 
to, polymerase chain reaction (PCR), restriction enZymes, 
expression vectors, plasmids, and the like. By Way of 
example, vectors may be designed Which contain a signal 
sequence. PCR ampli?ed DNA fragments of a modi?ed 
Rubisco large subunit éN-methyltransferase to be modi?ed 
may be digested by appropriate restriction enZymes and sub 
cloned into the vector. Modi?cations of the DNA may be 
introduced by standard molecular biological techniques as 
described above. 
Transformation 
In order to prepare the integration of foreign genes into 
higher plants a high number of cloning vectors are available, 
containing a replication signal for E. coli and a marker gene 
for the selection of transformed bacterial cells. Examples for 
such vectors include, but are not limited to, pBR322, pUC 
series, M13 mp series, pACYC184. The desired sequence 
may be integrated into the vector at a suitable restriction site. 
The obtained plasmid is used for the transformation of E. coli 
cells. Transformed E. coli cells are cultivated in a suitable 
medium end subsequently harvested and lysed. The plasmid 
is recovered. Restriction analysis, gel electrophoresis and 
other biochemico-molecular biological methods may be used 
to analyZe the obtained plasmid DNA. After each manipula 
tion the plasmid DNA may be cleaved and the obtained DNA 
fragments may be linked to other DNA sequences. Each 
plasmid DNA may be cloned into the same or into other 
plasmids. 
In order to integrate DNA into plant host cells a Wide range 
of techniques are available. These techniques comprise the 
transformation of plant cells With T-DNA by using Agrobac 
Zerium Zumefaciens orAgrobacZedium rhizogenes as transfor 
mation medium, the fusion of protoplasts, the injection and 
the electroporation of DNA, the integration of DNA by means 
of the biolistic method as Well as further possibilities. 
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Several modes of delivery of the DNA are knoW to those of 
skill in the art. For example, DNA may be delivered into the 
nuclear genome, or the chloroplast genome. If delivered into 
the nuclear genome, the construct Will have to an N-terminal 
sequence included in the construct capable of targeting the 
fusion to the chloroplast. This technique Well knoWn to one of 
skill in the art, may use the transit sequence for the SS of 
Rubisco, Which is knoWn to be chloroplast-localized, but is a 
nuclear-encoded gene. Alternatively, recent advances also 
alloW for delivery of the fusion construct directly into the 
chloroplast genome, Which obviates the necessity for a chlo 
roplast targeting sequence. These methods are described, for 
example, in Karlin, Neumann, GA. and Tobin, E. M., EMBO 
J. 5 (1986) 9-13; Liu,Y. Y., Kaderbhai, N., and Kaderbhai, M. 
A., Biochem. J. 351 Pt 2 (10-15-2000) 377-384; Mishkind, 
M. L., Wessler, S. R., and Schmidt, G. W., J. Cell Biol. 100 
(1985) 226-234; Huang, P. C., Klaus, S. M., HerZ, S., Zou, Z., 
Koop, H. U., and Golds, T. 1., Mol. Genet. Genomics 268 
(2002) 19-27; Madoka,Y., TomiZaWa, K., MiZoi, 1., Nishida, 
I., Nagano, Y., and Sasaki, Y., Plant Cell Physiol 43 (2002) 
1 51 8-1 525. 
In the case of injection and electroporation of DNA into 
plant cells, plasmids such as pUC derivatives may be used. 
HoWever, In cases in Which Whole plants are to be regenerated 
from transformed cells, a selectable marker gene should be 
present. 
Depending on the method used for integrating desired 
genes into the plant cell, further DNA sequences such as Ti 
and Ri-plasmid T-DNA may be necessary. 
If A grobacleria are used for the transformation, the DNA 
Which is to be integrated must be cloned into special plas 
mids, namely either into an intermediate vector or into a 
binary vector. Due to sequences homologous to the sequences 
Within the T-DNA, the intermediate vectors may be integrated 
into the Ti- or Ri-plasmid of the A grobaclerium due to 
homologous recombination. This also contains the vir-region 
necessary for the transfer of the T-DNA. Intermediate vectors 
cannot replicate in A grobacleria. By means of a helper plas 
mid the intermediate vector may be transferred to Agrobac 
Zerium Zumefaciens (conjugation). Binary vectors may repli 
cate in E. coli as Well as in A grobacleria. They contain a 
selectable marker gene as Well as a linker or polylinker Which 
is framed by the right and the left T-DNA border region. They 
may be transformed directly into the A grobacleria (Holsters 
et al. Mol. Gen. Genet. 163 (1978), 181-187). The Agrobac 
Zerium acting as host cell should contain a plasmid carrying a 
vir-region. The vir-region is necessary for the transfer of the 
T-DNA into the plant cell. Additional T-DNA may be present. 
The A grobaclerium transformed in such a Way is used for the 
transformation of plant cells. 
The use of T-DNA for the transformation of plant cells Was 
investigated intensely and described in EP 120 516; Hoe 
kema, In: The Binary Plant Vector System Offsetdrukkerij 
Kanters B. V., Alblasserdam (1985), Chapter V; Fraley et al., 
Crit. Rev. Plant. Sci., 4, 1-46 andAn et al. EMBO J. 4 (1985), 
277-287. 
For transferring the DNA into the plant cells, plant explants 
may suitably be co-cultivated With Agrobaclerium Zumefa 
ciens or A grobaclerium rhizogenes. From the infected plant 
material (eg pieces of leaves, stem segments, roots, but also 
protoplasts or suspension-cultivated plant cells) Whole plants 
may then be regenerated in a suitable medium Which may 
contain antibiotics or bioZides for the selection of trans 
formed cells. The plants obtained in such a Way may then be 
examined as to Whether the integrated DNA is present or not. 
Other possibilities in order to integrate foreign DNA by using 
the biolistic method or by transforming protoplasts are knoWn 
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to the skilledperson (cf., e. g., WillmitZer, L., 1993 Transgenic 
plants. In: Biotechnology, A Multi-Volume Comprehensive 
Treatise (H. J. Rehm, G. Reed, A. Puhler, P. Stadler, editors), 
Vol. 2, 627-659, VCH Weinheim-NeW York-Basel-Cam 
bridge). 
Once the introduced DNA has been integrated in the 
genome of the plant cell, it usually continues to be stable and 
also remains Within the descendants of the originally trans 
formed cell. It usually contains a selectable marker Which 
confers resistance against a bioZide or against an antibiotic 
such as kanamycin, G 418, bleomycin, hygromycin or phos 
phinotricine, etc. to the transformed plant cells. The individu 
ally selected marker should therefore alloW for a selection of 
transformed cells to cells lacking the integrated DNA. 
The transformed cells groW in the usual Way Within the 
plants (see also McCormick et al., 1986, Plant Cell Reports 5: 
81-84). 
The resulting plants can be cultivated in the usual Way and 
cross-bred With plants having the same transformed genetic 
heritage or another genetic heritage. The resulting hybrid 
individuals have the corresponding phenotypic properties. 
TWo or more generations should be groWn in order to ensure 
Whether the phenotypic feature is kept stably and Whether it is 
transferred. Furthermore, seeds should be harvested in order 
to ensure that the corresponding phenotype or other proper 
ties Will remain. 
Although the present invention has been described in detail 
With reference to examples above, it is understood that vari 
ous modi?cations can be made Without departing from the 
spirit of the invention, and Would be readily knoWn to the 
skilled artisan. Additionally, the invention is not to be con 
strued to be limited by the folloWing examples. 
EXAMPLES 
Example 1 
Materials and Methods 
Spinach Rubisco Was puri?ed and stored according to 
McCurry, S. D., Gee, R., and Tolbert, N. E. Methods Enzymol. 
90 Pt E, 515-521.1982. hCAll DNA Was transformed into 
BL21 DE3 pLYS S and expressed, puri?ed, and stored 
according to Tanhauser, S. M., JeWell, D. A., Tu, C. K., 
Silverman, D. N., and Laipis, P. J. Gene 117, 113-117.1992. 
hCAll Was assayed according to Cronk, J. D., EndriZZi, J. A., 
Cronk, M. R., O’neill, J. W., and Zhang, K.Y. Protein Sci. 10, 
911-922. 2001, Khalifah, R. G. The Journal ofBiological 
Chemistry 246, 2561-2573. 1971 Wilbur, K. M. and Ander 
son, N. G. TheJournal ofBiological Chemistry 176, 147-154. 
1948. Rubisco LSMT Was expressed, puri?ed, stored, and 
assayed according to Wang, P., Royer, M., and HoutZ, R. L. 
Protein Expr. Purif 6, 528-536. 1995. 
Example 2 
Binding of Rubisco LSMT and des(methyl) Forms 
of Rubisco 
Puri?ed Rubisco LSMT and hCAll (1 :8 M ratio) reacted in 
buffer A With 0.5% glutaraldehyde for 2 hours at room tem 
perature (approx. 220 C.). The glutaraldehyde Was quenched 
by the addition of Tris to 0.4 M, then dialyZed exhaustively in 
the microdialyZer (MWCO 8000) against buffer B at 4° C. 
Conjugated protein Was then incubated in buffer B With puri 
?ed spinach Rubisco (1 Rubisco:2 conjugate molar ratio) for 
4 hours on ice. The multienZyme complex (conjugate) Was 
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subjected to Sepharose CL 6B gel permeation chromatogra 
phy (1><45 cm column) and resolved at 0.1 mL/min into 0.5 
mL fractions. The Sepharose CL 6B column Was calibrated 
according to manufacturer’s instructions (FIG. 4). Fractions 
Were analyZed for Rubisco LSMT, Rubisco, and hCAll 
activities as described above. 
A human form of carbonic anhydrase (hCA) Was chemi 
cally cross-linked With Rubisco large subunit (LS) EN-Meth 
yltransferase (Rubisco LSMT). The complex betWeen hCA 
and Rubisco LSMT retained the highly speci?c and tight 
binding af?nity (KDEO.1 nM) for des(methyl) forms of 
Rubisco characteristic of Rubisco LSMT. Binding of this 
complex to Rubisco, and localiZation of carbonic anhydrase 
to the active-site vicinity of Rubisco, resulted in a signi?cant 
increase in the carboxylation ef?ciency of Rubisco mani 
fested as a decrease in the Km (CO2) from 13.4 uM to 3.44 uM 
(FIG. 4). Since the level of dissolved CO2 in equilibrium With 
air (—360 ppm) is approximately 15 uM, it has been Widely 
recogniZed for decades that a major limitation to plant pro 
ductivity and biomass production is the kinetic constraint for 
CO2 ?xation by Rubisco. At air levels of CO2, the enzymatic 
velocity for carboxylation by Rubisco is only half of the 
potential velocity, and additionally is further reduced by com 
petitive inhibition by oxygen. These tWo factors reduce the 
carboxylation ef?ciency of Rubisco, to the point that nearly 
all crop plants shoW a remarkable stimulation of groWth and 
productivity When cultured under atmospheres enriched in 
C02. The reduction in the apparent af?nity for CO2 by the 
direct placement of CA to the active-site vicinity of Rubisco 
circumvents these kinetic constraints and enables Rubisco, to 
maintain nearly saturated rates of carboxylation at air levels 
of CO2 (see FIG. 3, panel A and inset). It is contemplated in 
the present invention that these results can be duplicated 
using gene fusion techniques, and introduced into transgenic 
plants. The potential exists to increase plant productivity by 
50-100% in all C3 plants (a form of biochemical plant clas 
si?cation based on photosynthesis that represents the major 
ity of crop plants). 
FIG. 1. Estimation of the binding af?nity of Wild-type pea 
Rubisco LSMT for PVDF-immobiliZed des(methyl) spinach 
Rubisco. FIG. 1A shoWs the loss in Rubisco LSMT activity at 
4° C. from pea chloroplast lysates over time during incuba 
tion With PVDF-immobiliZed Rubisco. The concentration of 
Rubisco LSMT Was estimated at 58 nM from activity mea 
surements assuming a speci?c activity of puri?ed pea 
Rubisco LSMT of 306 nmoles/min/mg protein. FIG. 1B 
shoWs the loss in bound Rubisco LSMT activity at 4° C. from 
PVDF-immobiliZed spinach Rubisco over time as deter 
mined by activity measurements of bound Rubisco LSMT. 
Immunological analyses con?rmed that the loss in Rubisco 
LSMT activity Was due to disassociation and not catalytic 
inactivation. FIG. 1C shoWs an af?nity plot of data from FIG. 
1A and FIG. 1B estimating the af?nity constant KD for the 
binding of pea Rubisco LSMT to spinach Rubisco. 
Example 3 
Puri?cation of Rubisco LSMT and des(methyl) 
Forms of Rubisco 
Several studies have suggested that the activity of CA 
could be essential for optimum rates of photosynthetic CO2 
?xation in C3 plants at loW levels of CO2. Ample evidence 
exists for an essential role of CA in the CCM (carbon con 
centrating mechanism) in C4 plants, and aquatic species With 
CCMs. Other studies have identi?ed an association of CA 
With Calvin cycle enZymes and photosystem II complexes, as 
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Well as more de?ned localizations to pyrenoids and carboxy 
somes. However, direct experimental evidence of Whether or 
not a close association of CA With Rubisco results in 
increased rates of CO2 ?xation is unavailable. The possibility 
that CA placed in direct proximity to Rubisco in?uences the 
rate or extent of CO2 ?xation at loW CO2 by creating catalyti 
cally and binding competent conjugates betWeen HCAll (hu 
man carbon anhydrase H) and pea Rubisco LSMT Was 
explored in the present invention. This complex has a rela 
tively large molecular mass, binds to des(methyl) spinach 
Rubisco, retains CA, Rubisco LSMT, and Rubisco activity, 
and is immunologically reactive With Rubisco LSMT anti 
body (FIGS. 2A, B, and D). The complex does not bind to pea 
Rubisco (FIG. 2A). 
FIG. 2. Fractionation of human carbonic anhydrase H 
(HCAll)-Rubisco LSMT conjugate, Rubisco, Rubisco 
LSMT, and HCAll by chromatography on Sepharose 6B. 
Human carbonic anhydrase ll enzyme (HCAH), kindly pro 
vided by P. J. Laipis, Was induced according to Tanhauser, et 
al., Gene 117: 113-1 17 (1992), puri?ed according to Whitley, 
et al., Anal. Biochem. 57: 467-476 (1974), and assayed 
according to Cronk, et al., Protein Sci. 10: 911-922 (2001) 
(2.22 pmoles/min/ng protein, 3 Wilbur-Anderson (W-A) 
units/ pg). Spinach and pea Rubisco, and pea Rubisco LSMT 
Were puri?ed according to McCurry, et al., Methods Enzymol. 
90 Pt E: 515-521 (1982) and Zheng, et al., Protein Expr Purif.‘ 
14:104-112 (1998) respectively. Pea Rubisco LSMT and 
HCAll Were conjugated at a 1:8 molar ratio (240 pM:1.92 
mM) in 0.1 M potassium phosphate buffer, pH 6.8, by incu 
bation for 2 hours at 25° C. With (0.5% v/v) glutaraldehyde. 
Excess glutaraldehyde Was quenched by the addition of Tris 
buffer, pH 8.2, to 0.4 M and the reaction dialyzed exhaus 
tively against 50 mM Bicine, pH 8.2. The conjugated reaction 
products Were incubated With 10 mg of pea (A) or spinach (B) 
Rubisco for 2 hours at 250 C. The solution (0.5 mL) Was 
applied to a Sepharose 6B gel permeation column (15x45 
cm) and eluted at 0.1 mL/min in 50 mM Bicine pH 8.2. 
Protein concentration Was determined by the Bradford 
method. Pooled fractions Were enzymatically assayed for 
HCAll according to Cronk, et al., Protein Sci. 10: 911-922 
(2001) (A, pool 1, 1.69 W-A; B, pool 1, 1.46 W-A; B, pool 2, 
1.73 W-A), pea Rubisco LSMT (A, pool 1, 26600 pmoles/ 
min/mg protein; B, pool 1, 26600 pmoles/min/mg protein) 
and Rubisco carboxylase (A-pea, pool 2, 0.3 pmoles/min/mg 
protein; B-spinach, pool 1, 2.2 pmoles/min/mg protein). C, 
Coomassie-blue stained SDS-PAGE (15%; upper panel) and 
pea Rubisco LSMT immunoanalysis (loWer panel) of pooled 
fractions and enzymes described in B. A duplicate gel as in the 
upper panel Was electroblotted to a PVDF membrane, and 
probed With protein A-puri?ed anti-pea Rubisco LSMT anti 
body (1:10000). The pea Rubisco LSMT:HCAH conjugate 
Was of such high molecular mass that the immunoreactive 
band represents a complex that remained stacked just above 
the resolving gel such that a Coomassie-blue stained band is 
not visible in the upper panel. 
Example 4 
Effect of HCAll Conjugated to Rubisco LSMT on 
Carboxylase Activity of Spinach and Pea Rubisco 
Kinetic analyses Were performed as described previously 
for Rubisco Lorimer, G. H., Badger, M. R., and AndreWs, T. 
J. Biochemistry 15, 529-5361976. Pierce, J. W., McCurry, S. 
D., Mulligan, R. M., and Tolbert, N. E. Methods Enzymol. 89 
Pt D, 47-55.1982. Assays Were conducted under 02 free con 
ditions With COZ-free buffers as described beloW, and con 
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tained normalized Rubisco and hCAH activities, unless oth 
erWise indicated. The assays contained, unless otherWise 
indicated, 100 mM Bicine adjusted to pH 8.2 With a saturated 
NaOH solution, 20 mM MgCl2, 2 mM dithiothreitol, 0.5 mM 
RuBP, and NaHl4 CO3 (1.0 mCi/mmol). Reactions Were ini 
tiated by the addition of activated Rubisco, or conjugate, 
injected into an 8 mL serum capped vial (?rst ?ushed With 
nitrogen). Activation of Rubisco or conjugate Was performed 
at 2 mg/mL by incubation at 30 C for 15 min in 50 mM Bicine, 
pH 8.2, containing 20 mM MgCl2 and 15 mM NaHl4CO3. 
Assay times, enzyme masses, volumes, or speci?c activities 
Were adjusted to limit substrate consumption to 10% or less. 
The assays Were terminated by the addition by 2N HCl (0.4 
volumes), and the liquid evaporated to dryness under a stream 
of air at 500 C. Radioactivity Was determined With a liquid 
scintillation analyzer (Packard 2000 CA), after addition of 
0.5 mL H20 and 4.5 mL of cocktail (Bio-Safe H, RPl). 
Enzyme activity Was plotted verses substrate concentration 
and the data ?tted to the Michaelis-Menton equation using 
Sigma Plot version 8.0 
Under anaerobic conditions and utilizing COZ-free buffers, 
the carboxylase activity of spinach Rubisco (6 pg, 15 pM 
C02, 1 mM HCO3i, pH 8.2, 0.5 mM RuBP) remains linear 
until the ~4 nmoles of free C02 (250 pL assay volume) is 
consumed yielding a velocity of 0.83 pmoles/min/mg protein 
(~1/2 Vmax of 2.2 pmoles/min/mg protein), and then ceases as 
CO2 is totally depleted (FIG. 3A). In contrast an equal amount 
of spinach Rubisco (6 pg) With 0.89 W-A (Wilbur-Anderson 
units) of CA bound (equivalent to ~300 pg of native uncon 
jugated CA) under identical conditions exhibits linear CO2 
?xation for 2 min, at a velocity of 2.08 pmoles/min/mg pro 
tein. Addition of an equal amount of CA (300 ng) to control 
assays has no effect on the pro?le of CO2 ?xation (FIG. 3A). 
Increasing amounts of free CA to 10-fold more than bound 
(~3 pg, 10-fold molar excess over Rubisco) resulted in linear 
CO2 ?xation rates over the entire 2 min assay, at a velocity of 
0.83 pmoles/min/mg protein. HoWever, a 100-fold increase 
(also an ~100-fold molar excess over Rubisco) in the amount 
of free CA resulted in CO2 ?xation rates equal to that 
observed With 300 ng of bound CA. These differences are not 
observed at saturating levels of CO2, and CA inhibitors abol 
ished the effect of bound CA on carboxylase activity (FIG. 
3C). Carboxylase assays at saturating and loW CO2 shoWed 
no difference in activity betWeen native Rubisco and Rubisco 
With bound pea Rubisco LSMT alone. Thus, the effect of CA 
on the carboxylase activity of Rubisco appears to be a con 
sequence of localization through pea Rubisco LSMT binding 
to Rubisco. An ideal control to substantiate this observation 
Would be an identical conjugate With CA activity that did not 
bind to Rubisco. The conjugate betWeen pea Rubisco LSMT 
and CA retains Rubisco LSMT activity, and catalytic methy 
lation of des(methyl) spinach Rubisco by Rubisco LSMT 
results in release of Rubisco LSMT. Therefore We added 100 
pM AdoMet to the Rubisco complex containing bound CA 
prior to the initiation of carboxylase assays, and the effect of 
bound CA Was abolished (FIG. 3C). Furthermore, Rubisco 
because it contains a trimethyllysyl residue at position 14 in 
the LS, and similar experiments With pea Rubisco demon 
strated that the pea Rubisco LSMT CA conjugate did not bind 
to pea Rubisco (FIG. 2A), and no stimulation of carboxylase 
activity at loW CO2 Was observed With pea Rubisco (FIG. 3B). 
The decline in Rubisco carboxylase activity after 1 min Was 
not due to decarbamylation and inactivation of Rubisco, 
because addition of saturating levels of CO2 after 2 min (15 
mM HCO3i) to control assays resulted in velocities of 2.1 
pmoles/min/mg protein. 
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FIG. 3. Assays Were conducted under 02 free conditions 
With CO2-free buffers according to Lorimer, et al., Biochem 
islry 15: 529-536 (1976), altered as described below, and 
contained equal Rubisco activity and HCAII activity, unless 
otherWise indicated. The assays contained 100 mM Bicine 
adjusted to pH 8.2 With a saturated NaOH solution, 20 mM 
MgCl2, 2 mM dithiothreitol, 0.5 mM RuBP, and 15 pM 
NaH14CO3 (499-573 dpm/nmole). Reactions Were initiated 
by the addition of 6 pg of activated Rubisco, (activated at 2 
mg/mL by incubation at 30° C. for 15 min in 50 mM Bicine, 
pH 8.2, containing 20 mM MgCl2 and 15 mM NaH4CO3, 
(499-573 dpm/nmole), injected into an 8 mL serum-capped 
vial (?rst ?ushed With nitrogen). The assays Were conducted 
in a volume of 0.25 mL, terminated by the addition of 0.1 mL 
of 2 N HCl, and the liquid evaporated to dryness under a 
stream of air at 500 C. Radioactivity Was determined With a 
liquid scintillation analyZer (Packard 2000 CA), after the 
addition of 0.5 mL H20 and 4.5 mL of scintillation cocktail 
(Bio-Safe II, RPI). A, Acid-stable incorporation of 14CO2 
With time With spinach Rubisco (6 pg; Vmax:2.2 pmoles 
COZ/min/mg protein) With and Without pea Rubisco LSMT: 
HCAII conjugate (6 pg Rubisco, 0.9 W-A, equivalent to 0.3 
pg HCAII) or 0.3 (1><), 3.0 (10x), and 30 pg (100x) of free 
HCAII. Inset, Spinach Rubisco With pea Rubisco LSMT: 
HCAII conjugate preincubated With AdoMet (100 pM) or 
HCA II inhibitors (1.5 mM ampicillin and 0.5 mM acetaZola 
mide). B, Same condition as A but With pea Rubisco (46 pg, 
Vmax:0.3 pmoles COZ/min/mg protein) With and Without 
pea Rubisco LSMTzHCAII conjugate (0.9 W-A, equivalent to 
0.3 pg HCAII) or 0.3 pg HCAII (1><). 
FIG. 4 illustrates the kinetic analyses of Rubisco, Rubisco 
complexed With hCA, and Rubisco complexed With hCA in 
the presence of acetaZolamide (AZ). 
A mathematical consideration of the potential proximity 
effect of CA in these assays suggest that a maximum of 
~41-fold could be observed in terms of a decrease in the 
diffusion distance betWeen CO2 formed at the active-site of 
soluble CA compared to CA bound to Rubisco assuming a 
mean hydrodynamic radius of ~50 A for the distance of bound 
CA from the active-site of Rubisco (structural dimensions of 
HCAII a:43 A, b:42 A, c:73 A). At 6 pg/250 pL the con 
centration of Rubisco is 45 nM (~534,000 daltons). Free 
concentrations of CA at 0.3, 3, and 30 pg/250 pL represent 41 , 
410, and 4100 nM (~29,000 daltons). The molecular density 
of Rubisco at 45 nM is 2.7><101O molecules/mm3. Therefore 
the solution volume occupied by a single molecule of Rubisco 
at 45 nM is 3.7><101O A3, and a sphere containing this volume 
has a radius of2067 A. IfCA bound to Rubisco is Within ~50 
A (averaged dimensions of a CA tetrahedral) of the active-site 
then the ratio of the maximum distance betWeen bound and 
free CA is ~41 -fold. While the effectiveness of bound CA Was 
mimicked by 30 pg of unbound CA, and thus the e?iciency of 
bound CA is 100-fold greater, this effect has not been titrated 
and may therefore be overestimated, thus reducing the actual 
ef?ciency increase. Nevertheless, clearly the possibility exist 
that CA targeted to Rubisco has increased ef?ciency for sup 
porting carboxylase activity at loW CO2, by facilitating equi 
librium betWeen HCO3i and CO2 in direct proximity to the 
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active site of Rubisco. HoWever, the nearly saturated levels of 
carboxylase activity in the presence of conjugated bound CA, 
and the 100-fold molar excess of free CA, is not readily 
explainable. This effect Would presumably be manifested by 
a loWering of the aPPKm (CO2), but again hoW this might be 
accomplished is not clear. Perhaps the CA catalyZed equilib 
rium betWeen HCO3i and CO2 in proximity to Rubisco 
results in a temporary increase in CO2 above that Which 
Would be present With free CA, and the effects of a 100-fold 
molar excess of CA mimic this effect through such a large 
enZyme concentration. The possibility that such a large molar 
excess of free CA relative to Rubisco resulted in some non 
speci?c protein association Was addressed by incubation of 
CA and Rubisco at these ratios and subsequent gel-?ltration 
on Sepharose 6B as shoWn in FIG. 2. The results indicated no 
association betWeen Rubisco and CA even at a 100:1 molar 
ratio. 
Example 5 
Construction and Puri?cation of RLSMT-CA Fusion 
Protein 
The RLSMT Carbonic Anhydrase (RLSMT-CA) fusion 
Was constructed in a pET vector from Stratagene. The nucleic 
acid sequence encoding carbonic anhydrase (Accession num 
ber NMi000067) Was fused to the carboxyl terminus of Pea 
RLSMT (Accession number Q43088), and cloned into the 
pET vector using pET vector protocols from Stratagene and 
other standard molecular biology protocols. SEQ ID No.: 1 is 
the nucleic acid sequence of the RLSMT-CA. SEQ ID No.: 2 
is the amino acid sequence of the RLSMT-CA fusion protein. 
Again, using standard molecular biology protocols, this pET 
RLSMT-CA vector Was transformed into E. coli. E. coli 
expressing the pET-RLSMT-CA vector Were cultured under 
conditions suitable for expression of the RLSMT-CA fusion 
protein. ~130 ml of this culture Was pelleted, Washed, and 
lysed using standard protocols. This lysate Was resuspended 
in 5 ml standard buffer. 2.5 ml of this solution Was loaded onto 
~0.5 ml packed Spinach-Rubisco-conjugated activated 
Thiol-Sepharose 4B (T). 2.5 ml of this solution Was loaded 
onto ~1.0 ml packed Spinach-Rubisco-conjugated Cyanogen 
bromide-Activated Sepharose (C). The resin Was Washed 
With 40 ml of 0.4 M NaCl in standard buffer. RLSMT-CA 
eluted With AdoMet: about ~3 h With 100 pM AdoMet in 
standard buffer With 100 pg/ml [3-lactoglobulin (0.5 ml for T 
and 1.0 ml for C); concentrated With YM50. A Coomassie 
blue stained SDS-PAGE gel illustrating the elution of the 
RLSMT-CA is shoWn in FIG. 5. The Rubisco LSMT-CA 
fusion protein eluted in lanes 5 and 9 contained 22.3 pmoles/ 
min/ pl of Rubisco methyltransferase activity and 0007-0034 
Abs/ sec/ pl of carbonic anhydrase activity. 
While the invention has been described and illustrated 
herein by references to various speci?c material, procedures 
and examples, it is understood that the invention is not 
restricted to the particular material combinations of material, 
and procedures selected for that purpose. Numerous varia 
tions of such details can be implied as Will be appreciated by 
those skilled in the art. 
SEQUENCE LISTING 
SEQ ID NO 1 
LENGTH: 2181 
TYPE: DNA 
ORGANISM: 
FEATURE: 
artificial sequence 

21 
—cont inued 
US 8,138,309 B2 
22 
LENGTH: 
TYPE: 
ORGANISM: artificial sequence 
FEATURE: 
OTHER INFORMATION: RLSMT-CA fusion protein 
PRT 
<400> SEQUENCE: 
Met Ala Lys Ser 
1 
Ala 
Ala 
Val 
Lys 
65 
Arg 
Ile 
Ile 
Leu 
Lys 
145 
Leu 
Phe 
Asn 
Ala 
Gly 
225 
Val 
Asn 
Arg 
Phe 
Ala 
305 
Pro 
Glu 
Ser 
Lys 
Val 
Lys 
Ala 
50 
Arg 
Val 
Arg 
Leu 
130 
Glu 
Pro 
Trp 
Glu 
Gly 
210 
Leu 
Lys 
Ala 
His 
Asp 
290 
Tyr 
Tyr 
Ser 
Arg 
Ser 
370 
Gln 
Thr 
35 
Leu 
Leu 
Cys 
Glu 
Pro 
115 
Glu 
Tyr 
Asn 
Ala 
Asn 
195 
Val 
Phe 
Ala 
Glu 
Ala 
Asp 
Phe 
Leu 
Leu 
Asp 
355 
Ala 
Thr 
20 
Pro 
Lys 
Trp 
Ser 
Arg 
100 
Gln 
Leu 
Val 
Lys 
Phe 
180 
Leu 
Thr 
Ser 
Gly 
Leu 
260 
Tyr 
Lys 
Asp 
Arg 
Phe 
340 
Asn 
Leu 
728 
2 
Val 
5 
Phe 
Val 
Asp 
Ile 
Glu 
85 
Ser 
Glu 
Gln 
Lys 
Arg 
165 
Gly 
Val 
Thr 
Trp 
Glu 
245 
Ala 
Thr 
Leu 
Ile 
Leu 
325 
Arg 
Glu 
Ala 
Ala 
Trp 
Lys 
Ile 
Asn 
Leu 
Arg 
Thr 
Gly 
Asn 
150 
Leu 
Ile 
Val 
Glu 
Asp 
230 
Gln 
Leu 
Leu 
Asp 
Phe 
310 
Val 
Asp 
Glu 
Gly 
Ser 
Lys 
Ala 
Ser 
55 
Pro 
Lys 
Glu 
Asp 
Ser 
135 
Glu 
Phe 
Leu 
Val 
Asp 
215 
Tyr 
Val 
Asp 
Thr 
Val 
295 
Tyr 
Ala 
Thr 
Leu 
Tyr 
375 
Val 
Trp 
Ser 
40 
Arg 
Asp 
Pro 
Asp 
Ser 
120 
Gln 
Cys 
Pro 
Arg 
Pro 
200 
His 
Leu 
Tyr 
Tyr 
Leu 
280 
Ala 
Asn 
Leu 
Ile 
Leu 
360 
His 
Gly 
Leu 
25 
Val 
Asn 
Ala 
Trp 
Ser 
105 
Thr 
Leu 
Leu 
Asp 
Ser 
185 
Met 
Ala 
Phe 
Ile 
Gly 
265 
Glu 
Glu 
Arg 
Gly 
Trp 
345 
Cys 
Thr 
Thr 
10 
Gln 
Val 
Asp 
Val 
Leu 
90 
Val 
Ile 
Leu 
Lys 
Pro 
170 
Arg 
Ala 
Tyr 
Ser 
250 
Phe 
Ile 
Ser 
Thr 
Gly 
330 
Gly 
Lys 
Thr 
Glu 
Glu 
Thr 
Val 
Ala 
Ser 
Trp 
Tyr 
Lys 
Leu 
155 
Val 
Ala 
Asp 
Glu 
Leu 
235 
Tyr 
Ile 
Ser 
Asn 
Leu 
315 
Thr 
His 
Ala 
Ile 
Pro 
Glu 
Glu 
Ile 
Ala 
Val 
Lys 
Trp 
Thr 
140 
Glu 
Thr 
Phe 
Leu 
Val 
220 
Lys 
Asp 
Glu 
Glu 
Gly 
300 
Pro 
Asp 
Leu 
Val 
Glu 
380 
Ser 
Gly 
Gly 
45 
Leu 
Ser 
Ile 
His 
Ser 
125 
Thr 
Gln 
Leu 
Ser 
Ile 
205 
Lys 
Ser 
Leu 
Pro 
Ser 
285 
Phe 
Pro 
Ala 
Glu 
Arg 
365 
Gln 
Leu 
Val 
30 
Leu 
Gln 
Glu 
Leu 
Tyr 
110 
Glu 
Val 
Glu 
Asp 
Arg 
190 
Asn 
Gly 
Pro 
Asn 
Asn 
270 
Asp 
Ala 
Gly 
Phe 
Leu 
350 
Glu 
Asp 
Ser 
15 
Ile 
Gly 
Val 
Ile 
Phe 
95 
Phe 
Glu 
Ser 
Ile 
Asp 
175 
Leu 
His 
Ala 
Leu 
Lys 
255 
Glu 
Pro 
Gln 
Leu 
Leu 
335 
Ser 
Ala 
Arg 
Pro 
Thr 
Leu 
Pro 
Gly 
Leu 
Gly 
Glu 
Val 
Ile 
160 
Phe 
Arg 
Ser 
Ala 
Ser 
240 
Ser 
Asn 
Phe 
Thr 
Leu 
320 
Leu 
Val 
Cys 
Glu 
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Glu Ala 
395 
Leu Ser Leu 
390 
Leu Asn 
385 
Lys Gly Asp Arg 
Glu Glu Met Glu Thr Val Leu Gln Gln Ile Arg Gly Lys 
405 
Phe Glu Gln Lys Glu Leu Glu Leu Gln Leu Glu 
420 
Asp 
425 
Tyr 
Leu Glu Asn 
440 
Leu Leu 
435 
Arg Arg Lys Asp Gly Cys Gly Gly 
445 
Phe Phe 
455 
Gly Asp Leu Leu Glu 
450 
Gly Lys Gly Gly Gly 
460 
Gly 
Ala 
465 
Gly Glu Ser His His 
470 
Ser Leu Trp Gly Tyr 
475 
Gly Lys 
Glu Phe Ile 
490 
His Pro Ala 
485 
Pro His Trp Lys Asp Lys Gly 
Val I le Thr Thr 
505 
Ser Pro Asp His Ala 
500 
Asp Lys Tyr Asp 
Val Gln Ala Thr Leu 
525 
Leu Ser Ser Ser 
515 
Lys Pro Tyr Asp 
520 
Ala Phe Asn Val Glu Phe Ser 
535 
Asn His 
530 
Asn Gly Asp Asp 
540 
Ala 
545 
Val Thr 
555 
Leu Lys Gly Gly Pro Leu 
550 
Asp Gly Tyr Arg 
Phe His Phe His Trp Ser Leu Gln Ser 
565 
Gly Asp Gly 
570 
Gly 
Val Ala Ala Glu 
585 
Asp Lys Lys Leu His Leu Val 
580 
Lys Tyr 
Thr Phe Ala Val Gln Gln Pro 
605 
Lys Tyr 
595 
Gly Asp Gly Lys 
600 
Ala Val 
610 
I le Phe Val Ala 
620 
Leu Ser 
615 
Leu Gly Lys Gly Lys 
Gln 
625 
Val Val Val 
630 
Lys Asp Leu Asp Ser Ile Lys Thr 
635 
Lys 
Ala Phe Thr Asn Phe Pro Leu Leu Pro 
645 
Asp Asp Arg Gly 
650 
Thr 
660 
Leu Thr Thr Pro Pro 
665 
Asp Tyr Trp Tyr Pro Gly Ser 
Val Thr 
675 
Ile Val Glu Ile Val 
685 
Cys Trp Leu Lys Pro Ser 
680 
Gln Val 
690 
Leu Lys Phe Arg Lys Leu Asn Phe Asn Glu 
695 
Gly 
700 
Glu 
705 
Glu Met Val Ala Leu Asp Asn Pro Gln Pro 
710 
Trp Arg 
Gln Ile Ala 
725 
Arg Lys Ser Phe Lys 
Ile Ala Val Gly 
Asp 
Tyr 
430 
Asp 
Ser 
His 
Glu 
Pro 
510 
Arg 
Gln 
Leu 
Glu 
His 
590 
Asp 
Pro 
Gly 
Glu 
Leu 
670 
Ser 
Gly 
Leu 
Ile 
400 
Gly Ile 
415 
Gln Glu 
Ile Leu 
Ala Ala 
Asn Gly 
480 
Arg Gln 
495 
Ser Leu 
Ile Leu 
Asp Lys 
Ile Gln 
560 
His Thr 
575 
Trp Asn 
Gly Leu 
Leu Gly 
Ser 
640 
Lys 
Ser Leu 
655 
Leu Glu 
Ser Glu 
Glu Pro 
Asn 
720 
Lys 
The invention claimed is: 
1. A modi?ed Rubisco large subunit éN-methyltransferase 
(RLSMT), comprising a Rubisco large subunit éN-methyl 
transferase linked to a second molecule and Wherein the 
modi?ed RLSMT has the ability to bind a Rubisco. 
2. The modi?ed RLSMT of claim 1, Wherein the Rubisco 
large subunit éN-methyltransferase is linked to the second 
molecule by a chemical. 
3. The modi?ed RLSMT of claim 2, Wherein the chemical 
is glutaraldehyde. 
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4. The modi?ed RLSMT of claim 2, Wherein the modi?ed 
RLSMT is a fusion protein, Wherein the fusion protein is 
encoded by a nucleic acid, Wherein the nucleic acid comprises 
a ?rst nucleic acid encoding a Rubisco large subunit éN 
methyltransferase, and Wherein the nucleic acid further com 
prises a second nucleic acid encoding a polypeptide. 
5. The modi?ed RLSMT of claim 1, Wherein the second 
molecule is carbonic anhydrase. 
6. The modi?ed RLSMT of claim 1, Wherein the second 
molecule is a phosphatase, 3-phosphoglycerate kinase, glyc 
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eraldehydes-3-phosphate dehydrogenase, Rubisco Activase, 
Phosphoribulokinase, polylysine, or oxygenase. 
7. The modi?ed RLSMT of claim 1, wherein the modi?ed 
RLSMT is a fusion protein, Wherein the fusion protein is 
encoded by a nucleic acid. 
8. A modi?ed Rubisco large subunit éN-methyltransferase 
of claim 1, Wherein said second molecule is a carbonic anhy 
drase, Wherein the modi?ed RLSMT (RLSMT-CA) has the 
ability to bind a Rubisco large subunit. 
9. The modi?ed RLSMT of claim 8, Wherein the Rubisco 
large subunit éN-methyltransferase is linked to the carbonic 
anhydrase (CA) by a chemical. 
10. The modi?ed RLSMT of claim 9, Wherein the chemical 
is glutaraldehyde. 
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11. The modi?ed RLSMT of claim 8, Wherein the modi?ed 
RLSMT is a fusion protein, Wherein the fusion protein is 
encoded by a nucleic acid, Wherein the nucleic acid comprises 
a ?rst nucleic acid encoding a Rubisco large subunit éN 
methyltransferase, and Wherein the nucleic acid further com 
prises a second nucleic acid encoding a carbonic anhydrase. 
12. The modi?ed RLSMT of claim 8, Wherein the modi?ed 
RLSMT further comprises an antibody. 
13. The modi?ed RLSMT of claim 11, Wherein the anti 
body is linked to a CA. 
14. The modi?ed RLSMT of claim 8 comprising SEQ ID 
No.: 2. 
